<p>(A) IFN-γ production of peripheral blood NK cells [control subjects (n = 21), LCL patients (n = 28) and DCL patients (n = 6)]. Analysis in LCL patients [female (n = 11) and male (n = 17)] according to: (B) gender; (C) disease duration; (D) age. (E) Double immunohistochemical labelling (CD57<sup>+</sup>/IFN-γ<sup>+</sup>) in lesions of patients (LCL and DCL) showed redish-brown staining generated by the combination of a red AP substrate used for NK cells and DAB Black used for IFN-γ staining. □ Non-stimulated NK cells. ▪ LPG-stimulated NK cells. Mean ±SEM is shown. *p≤0.05 was considered significant. Scale bar = 50 µm. Black arrows show double positive cells.</p
<p>PBLs from the controls (N, <i>n</i> = 19) or patients with CRS (<i>n</i> = 18) were incubated wit...
<p><b>A</b>) PBMCs from two normal (healthy) donors (N1 and N2) and from the patient (P) were staine...
<p>Patients with CHB infection were treated with NA alone (<i>open circles</i>, n = 12–13) or togeth...
<p>(A) TNF-α production in peripheral blood [control subjects (n = 21), LCL patients (n = 28) and D...
<p>Human NK cells were cultured in the presence of IL-2 (100U/ml) and/or <i>M. bovis</i> BCG (MOI 1:...
<p>(A) Representative dot plots depict IFN-γ and CD107a expression by NK subsets from an HC subject ...
<p>(A) Double immunohistochemistry staining of TLR expression (TLR1, TLR2 and TLR6) on NK cells (CD5...
<p>NK-cell proportions and surface markers CD62L, CD57 and CD27 were analyzed with flow cytometry an...
The use of an IFN-γ ELISPOT assay to evaluate cellular immune responses has gained increasing popula...
<p><b>A</b>, surface expression of CD107a in resting (upper panels) and IL-2 activated NK cells (low...
<p>(A) B6 and BcA9 splenocytes were stimulated with indicated Pathogen-associated molecular patterns...
<p><b>(A)</b> NK cell infiltration of infected BL/6 or <i>IFNAR</i> KO mice. <b>(B)</b> Total accumu...
<p>Splenocytes from B6 and A-<i>Ly49h</i> mice were harvested and stimulated with RMAs-m157, BAF-m15...
<p>A—Analysis of NK-cell cytotoxicity following NK-cell activation with TLR9-stimulated pDCs in cont...
<p>The levels of MICA, MICB, ULBP1, ULBP2 and ULBP3 (A) and of nectin-2 and PVR (B) were assessed by...
<p>PBLs from the controls (N, <i>n</i> = 19) or patients with CRS (<i>n</i> = 18) were incubated wit...
<p><b>A</b>) PBMCs from two normal (healthy) donors (N1 and N2) and from the patient (P) were staine...
<p>Patients with CHB infection were treated with NA alone (<i>open circles</i>, n = 12–13) or togeth...
<p>(A) TNF-α production in peripheral blood [control subjects (n = 21), LCL patients (n = 28) and D...
<p>Human NK cells were cultured in the presence of IL-2 (100U/ml) and/or <i>M. bovis</i> BCG (MOI 1:...
<p>(A) Representative dot plots depict IFN-γ and CD107a expression by NK subsets from an HC subject ...
<p>(A) Double immunohistochemistry staining of TLR expression (TLR1, TLR2 and TLR6) on NK cells (CD5...
<p>NK-cell proportions and surface markers CD62L, CD57 and CD27 were analyzed with flow cytometry an...
The use of an IFN-γ ELISPOT assay to evaluate cellular immune responses has gained increasing popula...
<p><b>A</b>, surface expression of CD107a in resting (upper panels) and IL-2 activated NK cells (low...
<p>(A) B6 and BcA9 splenocytes were stimulated with indicated Pathogen-associated molecular patterns...
<p><b>(A)</b> NK cell infiltration of infected BL/6 or <i>IFNAR</i> KO mice. <b>(B)</b> Total accumu...
<p>Splenocytes from B6 and A-<i>Ly49h</i> mice were harvested and stimulated with RMAs-m157, BAF-m15...
<p>A—Analysis of NK-cell cytotoxicity following NK-cell activation with TLR9-stimulated pDCs in cont...
<p>The levels of MICA, MICB, ULBP1, ULBP2 and ULBP3 (A) and of nectin-2 and PVR (B) were assessed by...
<p>PBLs from the controls (N, <i>n</i> = 19) or patients with CRS (<i>n</i> = 18) were incubated wit...
<p><b>A</b>) PBMCs from two normal (healthy) donors (N1 and N2) and from the patient (P) were staine...
<p>Patients with CHB infection were treated with NA alone (<i>open circles</i>, n = 12–13) or togeth...